Sharon M Weber, MD, FACS

Professor

  • Chair, Division of Surgical Oncology
  • Medical Director of Surgical Oncology, UW Carbone Cancer Center
  • Endowed Professor, Tim and Mary Ann McKenzie Professorship in Surgical Oncology

webers@surgery.wisc.edu
(608) 262-2025

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Clinical Science Center
Madison, Wisconsin 53792-7375

Education

  • MD, University of Wisconsin Medical School, Madison, WI, 1993
  • Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1993-1999
  • Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI, 1996-1997
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 1999-2001
  • Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2000-2001

Clinical Specialties

Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.

Research Interests

Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors. Dr. Weber’s research interests also include mixed methods evaluation of risk factors for readmission using a systems engineering approach with a focus on the transition of care and outcomes research evaluating preoperative predictors of postoperative complications.

Recent Publications

  • Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors.
    Makris EA, Cannon JGD, Norton JA, Lopez-Aguiar AG, Dillhoff M, Beal E, Idrees K, Smith PM, Rocha FG, Kanji Z, Cho C, Beems M, Weber S, Fisher A, Krasnick BA, Fields RC, Maithel SK, Poultsides GA
    Ann Surg Oncol 2022 Nov 25;
    [PubMed ID: 36434481]

  • Impact of adjuvant therapy on outcomes after curative-intent resection for distal cholangiocarcinoma.
    Hou JJ, Maithel SK, Weber SM, Poultsides G, Wolfgang CL, Fields RC, He J, Scoggins C, Idrees K, Shen P, Zhang XF, Pawlik TM
    J Surg Oncol 2022 Nov 17;
    [PubMed ID: 36394450]

  • Impact of Preoperative Jaundice and Biliary Drainage on Short- and Long-term Outcomes among Patients with Gallbladder Cancer.
    Xiang JX, Maithel SK, Weber SM, Poultsides G, Wolfgang C, Jin L, Fields RC, Weiss M, Scoggins C, Idrees K, Shen P, Zhang XF, Pawlik TM
    J Gastrointest Surg 2022 Nov 14;
    [PubMed ID: 36376722]

  • ASO Visual Abstract: Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma.
    Spolverato G, Capelli G, Mari V, Lorenzoni G, Gregori D, Poultsides G, Fields RC, Weber SM, Votanopoulos K, Cho CS, He J, Maithel SK, Pucciarelli S, Pawlik TM
    Ann Surg Oncol 2022 Dec; 29(13): 8664-8665
    [PubMed ID: 36151428]

  • Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma.
    Spolverato G, Capelli G, Mari V, Lorenzoni G, Gregori D, Poultsides G, Fields RC, Weber SM, Votanopoulos K, Cho CS, He J, Maithel SK, Pucciarelli S, Pawlik TM
    Ann Surg Oncol 2022 Dec; 29(13): 8653-8661
    [PubMed ID: 36018525]

All Publications on PubMed